Madrigal Pharmaceuticals, Inc. (the ?Company?) reported that Remy Sukhija, who has served as the Company?s Chief Commercial Officer since April of 2020, is leaving the Company to pursue other opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.1 USD | +1.33% | +7.22% | -4.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.89% | 4.69B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- Madrigal Pharmaceuticals, Inc. Announces the Resignation of Remy Sukhija as Chief Commercial Officer